Skip to main content

Advertisement

Log in

Non-curative gastric resection for patients with stage 4 gastric cancer—a single center experience and current review of literature

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Purpose

The majority of patients with gastric cancer present with an advanced stage and, therefore, may not be eligible for curative treatment. The role of non-curative gastric resection in situations other than emergency treatment for life threatening tumor-related complications is still under discussion.

Methods

Data from 290 consecutive patients with advanced gastric cancer who were treated in our hospital were analyzed. A total of 48 patients underwent primary non-curative gastric resection.

Results

The overall survival in the non-curatively resected group was 15 months and 6 months for non-resected patients, respectively (p < 0.001). The incidence of tumor-related complications which required intervention was 63% in non-resected patients as compared to 12% in patients who underwent primary non-curative resection. Younger age, less than three tumor locations, and chemotherapy have been identified as prognostic factors for improved survival by univariate analysis. D3 lymph node involvement and chemotherapy were independent prognostic factors in the multivariate analysis. Peritoneal carcinosis did not significantly influence survival in resected patients. Non-curative resection in combination with chemotherapy resulted in longer overall survival than resection alone.

Conclusions

Primary non-curative gastric resection can reduce the incidence of severe tumor-related complications and can prolong overall survival in selected subgroups. In particular, younger patients with no more than two tumor locations should be considered for this procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ (2004) Cancer statistics, 2004. CA Cancer J Clin 54(1):8–29

    Article  PubMed  Google Scholar 

  2. Roukos DH, Kappas AM (2005) Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2(2):98–107. doi:10.1038/ncponc0099

    Article  PubMed  Google Scholar 

  3. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC (1989) Peritoneal carcinomatosis in nongynecologic malignancy: a prospective study of prognostic factors. Cancer 63(2):364–367

    Article  PubMed  CAS  Google Scholar 

  4. Feng XY, Chen YB, Chen S, Li YF, Zhou ZW, Li W, Zhan YQ, Sun XW, Xu DZ, Guan YX (2010) Relationship between the number of lymph node detection and prognosis in stage II( gastric cancer after D(2) dissection. Zhonghua Wei Chang Wai Ke Za Zhi 13(5):346–349

    PubMed  Google Scholar 

  5. Hundahl SA, Phillips JL, Menck HR (2000) The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer 88(4):921–932. doi:10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-S

    Article  PubMed  CAS  Google Scholar 

  6. Coburn NG (2009) Lymph nodes and gastric cancer. J Surg Oncol 99(4):199–206. doi:10.1002/jso.21224

    Article  PubMed  Google Scholar 

  7. Kim MC, Kim HH, Jung GJ, Lee JH, Choi SR, Kang DY, Roh MS, Jeong JS (2004) Lymphatic mapping and sentinel node biopsy using 99mTc tin colloid in gastric cancer. Ann Surg 239(3):383–387

    Article  PubMed  Google Scholar 

  8. Shah MA, Kelsen DP (2010) Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. J Natl Compr Canc Netw 8(4):437–447

    PubMed  CAS  Google Scholar 

  9. Wagner AD, Unverzagt S, Grothe W, Kleber G, Grothey A, Haerting J, Fleig WE (2010) Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev 3:CD004064. doi:10.1002/14651858.CD004064.pub3

  10. Nishiyama M, Wada S (2009) Docetaxel: its role in current and future treatments for advanced gastric cancer. Gastric Cancer 12(3):132–141. doi:10.1007/s10120-009-0521-z

    Article  PubMed  CAS  Google Scholar 

  11. Meza-Junco J, Au HJ, Sawyer MB (2009) Trastuzumab for gastric cancer. Expert Opin Biol Ther 9(12):1543–1551. doi:10.1517/14712590903439702

    Article  PubMed  CAS  Google Scholar 

  12. Lawrence W Jr, Mc NG (1958) The effectiveness of surgery for palliation of incurable gastric cancer. Cancer 11(1):28–32

    Article  PubMed  Google Scholar 

  13. ReMine WH (1979) Palliative operations for incurable gastric cancer. World J Surg 3(6):721–729

    Article  PubMed  CAS  Google Scholar 

  14. Bozzetti F, Bonfanti G, Audisio RA, Doci R, Dossena G, Gennari L, Andreola S (1987) Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet 164(2):151–154

    PubMed  CAS  Google Scholar 

  15. Hartgrink HH, Putter H, Klein Kranenbarg E, Bonenkamp JJ, van de Velde CJ (2002) Value of palliative resection in gastric cancer. Br J Surg 89(11):1438–1443. doi:10.1046/j.1365-2168.2002.02220.x

    Article  PubMed  CAS  Google Scholar 

  16. Lin SZ, Tong HF, You T, Yu YJ, Wu WJ, Chen C, Zhang W, Ye B, Li CM, Zhen ZQ, Xu JR, Zhou JL (2008) Palliative gastrectomy and chemotherapy for stage IV gastric cancer. J Cancer Res Clin Oncol 134(2):187–192. doi:10.1007/s00432-007-0268-z

    Article  PubMed  CAS  Google Scholar 

  17. Huang KH, Wu CW, Fang WL, Chen JH, Lo SS, Wang RF, Li AF Palliative resection in noncurative gastric cancer patients. World J Surg 34 (5):1015-1021. doi:10.1007/s00268-010-0467-7

  18. Miner TJ, Jaques DP, Karpeh MS, Brennan MF (2004) Defining palliative surgery in patients receiving noncurative resections for gastric cancer. J Am Coll Surg 198(6):1013–1021. doi:10.1016/j.jamcollsurg.2004.02.007S1072-7515(04)00149-8

    Article  PubMed  Google Scholar 

  19. Moehler M, Galle PR, Gockel I, Junginger T, Schmidberger H (2007) The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer. Best Pract Res Clin Gastroenterol 21(6):965–981. doi:10.1016/j.bpg.2007.10.003

    Article  PubMed  CAS  Google Scholar 

  20. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49

    PubMed  CAS  Google Scholar 

  21. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187–196. doi:10.1097/SLA.0b013e3181b13ca2

    Article  PubMed  Google Scholar 

  22. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213

    Article  PubMed  Google Scholar 

  23. Kunisaki C, Makino H, Takagawa R, Oshima T, Nagano Y, Fujii S, Otsuka Y, Akiyama H, Ono HA, Kosaka T, Ichikawa Y, Shimada H (2008) Impact of palliative gastrectomy in patients with incurable advanced gastric cancer. Anticancer Res 28(2B):1309–1315

    PubMed  Google Scholar 

  24. Wang CS, Chao TC, Jan YY, Jeng LB, Hwang TL, Chen MF (2002) Benefits of palliative surgery for far-advanced gastric cancer. Chang Gung Med J 25(12):792–802

    PubMed  Google Scholar 

  25. Sarela AI, Miner TJ, Karpeh MS, Coit DG, Jaques DP, Brennan MF (2006) Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma. Ann Surg 243(2):189–195. doi:10.1097/01.sla.0000197382.43208.a500000658-200602000-00007

    Article  PubMed  Google Scholar 

  26. Meyer LRK, Meyer F, Gastinger I, Lippert H (2008) Qualitätssicherungsstudie zum Magenkarzinom in Deutschland. Der Onkologe 14:396–402. doi:10.1007/s00761-008-1340-2

    Article  Google Scholar 

  27. Ouchi K, Sugawara T, Ono H, Fujiya T, Kamiyama Y, Kakugawa Y, Mikuni J, Yamanami H (1998) Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 69(1):41–44. doi:10.1002/(SICI)1096-9098(199809)69:1<41::AID-JSO8>3.0.CO;2-K

    Article  PubMed  CAS  Google Scholar 

  28. Adachi Y, Aramaki M, Shiraishi N, Shimoda K, Yasuda K, Kitano S (1998) Long-term survival after perforation of advanced gastric cancer: case report and review of the literature. Gastric Cancer 1(1):80–83. doi:10.1007/s101209800024

    Article  PubMed  Google Scholar 

  29. Mizutani S, Shioya T, Maejima K, Yoshino M, Komine O, Bou H, Ogata M, Watanabe M, Shibuya T, Tokunaga A, Tajiri T (2007) Significance of gastrectomy as palliative surgery for gastric carcinoma with pyloric stenosis. J Nippon Med Sch 74(3):241–245

    Article  Google Scholar 

  30. Onate-Ocana LF, Mendez-Cruz G, Hernandez-Ramos R, Becker M, Carrillo JF, Herrera-Goepfert R, Aiello-Crocifoglio V, Ochoa-Carrillo F, Beltran-Ortega A (2007) Experience of surgical morbidity after palliative surgery in patients with gastric carcinoma. Gastric Cancer 10(4):215–220. doi:10.1007/s10120-007-0437-4

    Article  PubMed  Google Scholar 

  31. Lim S, Muhs BE, Marcus SG, Newman E, Berman RS, Hiotis SP (2007) Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups? J Surg Oncol 95(2):118–122. doi:10.1002/jso.20328

    Article  PubMed  Google Scholar 

  32. Nazli O, Yaman I, Tansug T, Isguder AS, Bozdag AD, Bolukbasi H (2007) Palliative surgery for advanced stage (stage IV) gastric adenocarcinoma. Hepatogastroenterology 54(73):298–303

    PubMed  Google Scholar 

  33. Saidi RF, ReMine SG, Dudrick PS, Hanna NN (2006) Is there a role for palliative gastrectomy in patients with stage IV gastric cancer? World J Surg 30(1):21–27. doi:10.1007/s00268-005-0129-3

    Article  PubMed  Google Scholar 

  34. Medina-Franco H, Contreras-Saldivar A, Ramos-De La Medina A, Palacios-Sanchez P, Cortes-Gonzalez R, Ugarte JA (2004) Surgery for stage IV gastric cancer. Am J Surg 187(4):543–546. doi:10.1016/j.amjsurg.2003.12.045

    Article  PubMed  Google Scholar 

  35. Monson JR, Donohue JH, McIlrath DC, Farnell MB, Ilstrup DM (1991) Total gastrectomy for advanced cancer. A worthwhile palliative procedure. Cancer 68(9):1863–1868

    Article  PubMed  CAS  Google Scholar 

  36. Meijer S, De Bakker OJ, Hoitsma HF (1983) Palliative resection in gastric cancer. J Surg Oncol 23(2):77–80

    Article  PubMed  CAS  Google Scholar 

  37. Yao Z, Mishra L (2009) Cancer stem cells and hepatocellular carcinoma. Cancer Biol Ther 8(18):1691–1698

    Article  PubMed  CAS  Google Scholar 

  38. Tan S, Chen JS, Sun LJ, Yao HR (2009) Selective enrichment of hepatocellular cancer stem cells by chemotherapy. J Int Med Res 37(4):1046–1056

    PubMed  CAS  Google Scholar 

  39. Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, Shetty K, Johnson L, Reddy EP (2009) Liver stem cells and hepatocellular carcinoma. Hepatology 49(1):318–329. doi:10.1002/hep.22704

    Article  PubMed  Google Scholar 

  40. Koller M, Kussmann J, Lorenz W, Rothmund M (1994) Measuring quality of life in after-care of tumor surgery. Methods, problems and applications. Chirurg 65(4):333–339

    PubMed  CAS  Google Scholar 

  41. Gilbertsen VA (1969) Results of treatment of stomach cancer. An appraisal of efforts for more extensive surgery and a rort of 1,983 cases. Cancer 23(6):1305–1308

    Article  PubMed  CAS  Google Scholar 

  42. Yu D, Hung MC (2000) Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 19(53):6115–6121. doi:10.1038/sj.onc.1203972

    Article  PubMed  CAS  Google Scholar 

  43. Dittmar Y, Posorski N, Rauchfuss F, Voigt R, Heise M, Jandt K, Gajda M, Settmacher U (2010) Relationship between degree of chromosomal aberration and survival in intestinal-type gastric cancer—a preliminary report based on three cases of hepatic metastasized gastric cancer with long-time survival. Onkologie 33(11):591–596. doi:10.1159/000321143

    Article  PubMed  Google Scholar 

  44. Sugarbaker PH, Yu W, Yonemura Y (2003) Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin Surg Oncol 21(4):233–248. doi:10.1002/ssu.10042

    Article  PubMed  Google Scholar 

  45. Glockzin G, Schlitt HJ, Piso P (2009) Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 7:5. doi:10.1186/1477-7819-7-5

    Article  PubMed  Google Scholar 

  46. Iesalnieks I, Kullmann F, Dahlke M, Ghali N, Agha A, von Breitenbuch P, Schoelmerich J, Schlitt HJ, Piso P (2006) Surgical management of patients with peritoneal carcinomatosis of gastrointestinal origin. Z Gastroenterol 44(12):1237–1245. doi:10.1055/s-2006-927156

    Article  PubMed  CAS  Google Scholar 

  47. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yves Dittmar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dittmar, Y., Rauchfuss, F., Goetz, M. et al. Non-curative gastric resection for patients with stage 4 gastric cancer—a single center experience and current review of literature. Langenbecks Arch Surg 397, 745–753 (2012). https://doi.org/10.1007/s00423-012-0902-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-012-0902-3

Key words

Navigation